Professor Rafael Beyar

• Professor Emeritus, The Bruce and Ruth Rappaport Faculty of Medicine, Technion
• Co-Founder and Member, the Israeli National Academy for Science in   Medicine
• President, International Friends Associations, Rambam Health Care Campus
• Interventional Cardiologist, Rambam
•  Managing General Partner, Alive Health Tech Fund
  

Professor Rafael (Rafi) Beyar, is an interventional cardiologist, a biomedical engineer and an innovator, former director of Rambam Health Care Campus (2006-2019), Professor Emeritus of Medicine and Biomedical Engineering at the Technion and former Dean of the Faculty of Medicine (1999-2004). He is a visiting professor at Johns Hopkins University.  Beyar received an MD from Tel Aviv University, DSc in Biomedical Engineering from the Technion, and MPH from the Bloomberg School of Public Health, Johns Hopkins University. He trained at Rambam and Johns Hopkins Cardiology.

Beyar Research interests are cardiovascular simulations, coronary stents and cardiovascular robotics. He has authored more than 230 publications and 15 books, and is the recipient of numerous awards. During his term as Dean he established the Johns Hopkins Technion-Collaboration Program and Professors Hershko and Chechakoes were awarded the Nobel Prize in Chemistry (2004). Beyar led the hospital through the 2006 Second Lebanon War, when it was under rocket attack. He led the vision and development of the hospital’s 2,000-bed Fortified Underground Emergency Hospital, the Children’s Hospital, the Oncology Center, and the Heart Hospital.  The Health Discovery Tower at the center of the campus currently underway, is a premiere integrated research and innovation hub, in collaboration with the Technion, University of Haifa and the industry.  Beyar founded the hospital’s technology transfer company, Rambam MedTech and the Mind-Up Incubator with Rambam, Medtronic, IBM Pitango and Impact first.  Beyar served as chair of the Israeli Basket Committee and serves as the chair of the Steering Committee for the Israeli Organ Transplant Center.

Beyar co-founded Intent, which was acquired by Medtronic and NaviCath (later Corindus), a Technion Incubator Company, the first-in-the-world robotic coronary intervention, which was acquired by Siemens Healthineers. He currently serves as director of Rambam Med-Tech and is serving as director or advisor in several start-up companies.  After his term as Director of Rambam he co-founded and serves as managing general partner at ALIVE Israel HealthTech fund.   He founded and co-chairs with Professor Chaim Lotan the international meeting, Innovation in Cardiovascular Interventions (ICI) since 1996. He served as the Chairman of the National Committee appointed by the Council for Higher Education for Medical school curriculum and clinical fields and was a member in the Bioconvergence committee by the Innovation Authority.